The Medical Research Network, LLC   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: New York NY United States (1997)

Organization Overview

First Clinical Trial
2005
NCT00237666
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Liebowitz, Michael R., M.D. | Medical Research Network | Medical Research Network, L.L.C. | The Medical Research Network

Active Ingredients

Drugs in Phase 4 Trials (4)

cariprazine (vraylar) (1 trial)

desvenlafaxine (pristiq) (1 trial)

vortioxetine (trintellix) (1 trial)

ziprasidone (geodon) (1 trial)

Drugs in Phase 3 Trials (1)

Fasedienol (4 trials)

Drugs in Other Trials (1)

vilazodone (viibryd) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anxiety Disorders (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Disease (Phase 4)

Phobia, Social (Phase 4)

Phobic Disorders (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 6